| 查看: 771 | 回复: 1 | ||
| 【悬赏金币】回答本帖问题,作者苏文龙将赠送您 65 个金币 | ||
[求助]
BMC Genomics投稿求助
|
||
|
BMC Genomics文章接受了,给出了修改意见,请大神帮忙看看该怎么弄呀。 2. Availability of Supporting Data section: We encourage authors whose supporting data are available in an open access repository to include an ?Availability of supporting data? section in their manuscript, before the Competing interests and Authors? contributions. The section should state the name of the repository in which your data is deposited and include a link to the dataset DOI. If all the supporting data are included as additional files the section should state this. If your manuscript has any supporting sequence data, microarray data, or proteomic data this must be deposited in the appropriate repository and a link to the dataset should be included in the Availability of supporting data section. Deposition of other supporting data is encouraged. Through a special arrangement with LabArchives, LLC (https://www.labarchives.com/), authors submitting manuscripts to BioMed Central journals can obtain a complimentary subscription to LabArchives (https://www.labarchives.com/bmc) with an allotment of 100MB of storage. LabArchives is an Electronic Laboratory Notebook which enables scientists to share and publish data files in situ; you can then link your article to these data using the ?Availability of supporting data? section. Clinical data can be deposited if consent to do so was obtained before the study began, in which case a statement should be in the manuscript, or if the data is deposited in a repository in an anonymized form that complies with data protection/privacy laws. For more information on supporting data please see the following https://www.biomedcentral.com/about/supportingdata. |
» 猜你喜欢
有时候真觉得大城市人没有县城人甚至个体户幸福
已经有9人回复
CSC & MSCA 博洛尼亚大学能源材料课题组博士/博士后招生|MSCA经费充足、排名优
已经有6人回复
天津大学招2026.09的博士生,欢迎大家推荐交流(博导是本人)
已经有4人回复
同年申请2项不同项目,第1个项目里不写第2个项目的信息,可以吗
已经有3人回复
退学或坚持读
已经有28人回复
面上项目申报
已经有3人回复
酰胺脱乙酰基
已经有9人回复
博士延得我,科研能力直往上蹿
已经有7人回复
面上基金申报没有其他的参与者成吗
已经有5人回复
遇见不省心的家人很难过
已经有22人回复
2楼2016-01-31 16:48:14













回复此楼